25,000 Doses Of Remdesivir From Gilead Sciences Reaches India
Last month, Gilead spokesperson had told Sputnik that it will provide all its licensing partners in India with the technical support for the addition of new manufacturing facilities but will not send any more specialists there. The third consignment consisting of 25000 doses of Remdesivir from American biopharmaceutical company Gilead Sciences reached India on Saturday. The information was shared by Taranjit Singh Sandhu, Ambassador of India to the United States on Twitter. “Third consignment from @GileadSciences of 25000 doses of Remdesivir from United States reach India! 180000 doses have reached…
Read More